Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing … Read more
Advanced Enzyme Technologies Limited (ADVENZYMES) - Total Assets
Latest total assets as of September 2025: ₹16.92 Billion INR
Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) holds total assets worth ₹16.92 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Advanced Enzyme Technologies Limited - Total Assets Trend (2008–2025)
This chart illustrates how Advanced Enzyme Technologies Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Advanced Enzyme Technologies Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Advanced Enzyme Technologies Limited's total assets of ₹16.92 Billion consist of 54.3% current assets and 45.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹667.50 Million | 6.6% |
| Accounts Receivable | ₹1.16 Billion | 7.2% |
| Inventory | ₹1.57 Billion | 9.7% |
| Property, Plant & Equipment | ₹3.15 Billion | 19.4% |
| Intangible Assets | ₹523.08 Million | 3.2% |
| Goodwill | ₹3.33 Billion | 20.6% |
Asset Composition Trend (2008–2025)
This chart illustrates how Advanced Enzyme Technologies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Advanced Enzyme Technologies Limited's current assets represent 54.3% of total assets in 2025, an increase from 40.4% in 2008.
- Cash Position: Cash and equivalents constituted 6.6% of total assets in 2025, up from 0.5% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 20.6% of total assets.
Advanced Enzyme Technologies Limited Competitors by Total Assets
Key competitors of Advanced Enzyme Technologies Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel N.V
OTCQX:AKZOF
|
USA | $13.95 Billion |
|
YeSUN Tech Co.Ltd.
KQ:250930
|
Korea | ₩51.65 Billion |
|
Hangzhou Flariant Co Ltd
SHG:605566
|
China | CN¥2.55 Billion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
DL Holdings CO. LTD.
KO:000210
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
Advanced Enzyme Technologies Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Advanced Enzyme Technologies Limited generates 0.39x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Advanced Enzyme Technologies Limited generates $8.09 in net profit.
Advanced Enzyme Technologies Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.75 | 7.75 | 7.27 |
| Quick Ratio | 7.12 | 6.13 | 5.81 |
| Cash Ratio | 0.72 | 1.07 | 0.00 |
| Working Capital | ₹8.27 Billion | ₹ 7.01 Billion | ₹ 3.84 Billion |
Advanced Enzyme Technologies Limited - Advanced Valuation Insights
This section examines the relationship between Advanced Enzyme Technologies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.19 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 5.6% |
| Total Assets | ₹16.21 Billion |
| Market Capitalization | $95.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Advanced Enzyme Technologies Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Advanced Enzyme Technologies Limited's assets grew by 5.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Advanced Enzyme Technologies Limited (2008–2025)
The table below shows the annual total assets of Advanced Enzyme Technologies Limited from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹16.21 Billion | +5.59% |
| 2024-03-31 | ₹15.35 Billion | +7.99% |
| 2023-03-31 | ₹14.22 Billion | +12.17% |
| 2022-03-31 | ₹12.68 Billion | +9.97% |
| 2021-03-31 | ₹11.53 Billion | +17.79% |
| 2020-03-31 | ₹9.79 Billion | +20.65% |
| 2019-03-31 | ₹8.11 Billion | +10.86% |
| 2018-03-31 | ₹7.32 Billion | +26.90% |
| 2017-03-31 | ₹5.77 Billion | +27.98% |
| 2016-03-31 | ₹4.51 Billion | +8.32% |
| 2015-03-31 | ₹4.16 Billion | +2.42% |
| 2014-03-31 | ₹4.06 Billion | +2.54% |
| 2013-03-31 | ₹3.96 Billion | +13.36% |
| 2012-03-31 | ₹3.49 Billion | +126.89% |
| 2011-03-31 | ₹1.54 Billion | +41.17% |
| 2010-03-31 | ₹1.09 Billion | +15.98% |
| 2009-03-31 | ₹940.41 Million | +3.74% |
| 2008-03-31 | ₹906.55 Million | -- |